According to an FDA Enforcement Report, Teva is recalling four sterile injectable drugs manufactured at the company's banned plant in Hungary.
Specifically, Teva is recalling 92,480 containers of antibiotic linezolid; 14,661 vials of eptifibatide; 13,223 vials of ondansetron; and 1,299 bags of argatroban all of which came from the 15,000-square-meter Hungarian facility.
Teva put a temporary halt on production at the plant after the FDA had discovered manufacturing issues during a January inspection. This was followed in May by an import alert that banned all sterile injectables produced from the plant with the exception of amikacin and bleomycin.
Read the Market Exclusive coverage